Data as of Dec 10
| -0.14 / -0.20%|
Smith & Nephew Plc is a global orthopedics company. It develops, manufactures, markets and sells medical devices in the sectors of advanced medical devices and advanced wound management. The company operates in three segments: Orthopedics, Endoscopy and Advanced Wound Management. The Orthopedics segment comprises reconstruction implants, including hip, knee and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. This segment also provides trauma fixation products consisting of internal and external devices, and shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures and clinical therapies products comprising bone growth stimulation, joint fluid therapies and outpatient spine products. The Endoscopy segment develops and commercializes minimally invasive surgery techniques, educational programs and value-added services for surgeons to treat and repair soft tissue and articulating joints. It offers specialized devices and fixation systems to repair damaged tissues; fluid management equipment for surgical access; digital cameras, digital image capture, scopes, light sources, and monitors to assist with visualization; radiofrequency wands, electromechanical and mechanical blades and hand instruments for resecting damaged tissues. The Advanced Wound Management segment offers a range of products from initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers and products for the treatment of wounds, including burns and invasive surgery. Smith & Nephew was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.
|Olivier Jean Bohuon||Chief Executive Officer & Director|
|Jeffrey Adams||Senior Vice President-Global Operations|
|Julie Brown||Chief Financial Officer & Executive Director|
|Naseem Amin||Chief Scientific Officer|
|Ros Rivaz||Chief Technology Officer|